Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Aminosalicilatos para la inducción de remisión o respuesta en la enfermedad de Crohn

Esta versión no es la más reciente

ver la versión actual 03 julio 2016

Información

DOI:
https://doi.org/10.1002/14651858.CD008870Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 08 diciembre 2010see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Salud digestiva

Copyright:
  1. Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Wee‐Chian Lim

    Correspondencia a: Department of Gastroenterology and Hepatology, Tan Tock Seng Hospital, Singapore, Singapore

    [email protected]

    [email protected]

  • Stephen Hanauer

    University of Chicago Medical Centre, Chicago, USA

Declarations of interest

Wee‐Chian Lim: None known

Stephen Hanauer: consulting for Shire (Advisory Board), Salix (Advisory Board), Meda Pharma (Advisory Board), Centocor (Advisory Board), Prometheus (Advisory Board), Abbott (Advisory Board & Consulting), UCB (Advisory Board), Elan (Advisory Board), Caremark National Formulary (Consulting), Ferring (Not in past 2 years); grants or grants pending from Shire (Fellowship support), Centocor (Clinical trial support), Abbott (Clinical trial support), UCB (Clinical trial support); payment for lectures from Warner Chilcotte; payment for development of educational presentations from Shire; travel/accommodations/meeting expenses unrelated to above from Falk (Falk Symposia); member Board of Trustees, American College of Gastroenterology; member Specialty Board of Gastroenterology, American Board of Internal Medicine.

Acknowledgements

The authors would like to thank Thomas Bockle M.D. for his assistance in translating the German‐language article.

Funding for the IBD/FBD Review Group (September 1, 2010 ‐ August 31, 2015) has been provided by the Canadian Institutes of Health Research (CIHR) Knowledge Translation Branch (CON ‐ 105529) and the CIHR Institutes of Nutrition, Metabolism and Diabetes (INMD); and Infection and Immunity (III).

Miss Ila Stewart has provided support for the IBD/FBD Review Group through the Olive Stewart Fund.

Version history

Published

Title

Stage

Authors

Version

2016 Jul 03

Aminosalicylates for induction of remission or response in Crohn's disease

Review

Wee‐Chian Lim, Yongjun Wang, John K MacDonald, Stephen Hanauer

https://doi.org/10.1002/14651858.CD008870.pub2

2010 Dec 08

Aminosalicylates for induction of remission or response in Crohn's disease

Review

Wee‐Chian Lim, Stephen Hanauer

https://doi.org/10.1002/14651858.CD008870

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.